Literature DB >> 31352401

Isolated growth hormone deficiency presenting with recurrent hypoglycaemia in a toddler.

Hiya Boro1, Alpesh Goyal2, Rajesh Khadgawat2.   

Abstract

Hypoglycaemia in infants and children is caused by a number of endocrine and metabolic defects, some of which are unique to this age group. Growth hormone deficiency (GHD) has been rarely reported as a cause of recurrent fasting hypoglycaemia in children. An 18-month-old male child presented to us for evaluation of neuroglycopenic symptoms caused by recurrent episodes of fasting hypoglycaemia. Laboratory evaluation revealed ketotic hypoinsulinaemic hypoglycaemia. The child was diagnosed to have GHD on the basis of two failed stimulation tests. A detailed work-up for metabolic and other hormonal causes of hypoglycaemia was negative. We present the case for its rarity and to highlight the importance of a detailed metabolic and hormonal assessment in evaluation of childhood hypoglycaemia. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  endocrine system; metabolic disorders; paediatrics (drugs and medicines); pituitary disorders

Mesh:

Substances:

Year:  2019        PMID: 31352401      PMCID: PMC6663260          DOI: 10.1136/bcr-2019-231056

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  HYPOGLYCEMIA, GROWTH RETARDATION, AND PROBABLE ISOLATED GROWTH HORMONE DEFICIENCY IN A 1-YEAR-OLD CHILD.

Authors:  H L NADLER; L L NEUMANN; H GERSHBERG
Journal:  J Pediatr       Date:  1963-11       Impact factor: 4.406

2.  HYPOGLYCEMIA AND DWARFISM ASSOCIATED WITH THE ISOLATED DEFICIENCY OF GROWTH HORMONE.

Authors:  J F WILBER; W D ODELL
Journal:  Metabolism       Date:  1965-05       Impact factor: 8.694

Review 3.  Approach to hypoglycemia in infants and children.

Authors:  Kajal Gandhi
Journal:  Transl Pediatr       Date:  2017-10

4.  Endocrine control of growth.

Authors:  Philip G Murray; Peter E Clayton
Journal:  Am J Med Genet C Semin Med Genet       Date:  2013-05       Impact factor: 3.908

5.  Effect of growth hormone treatment on hypoglycemia in a patient with both hepatic glycogen synthase and isolated growth hormone deficiencies.

Authors:  P Blümel; P E Mullis
Journal:  J Pediatr Endocrinol Metab       Date:  2001 Sep-Oct       Impact factor: 1.634

6.  Recurrent infantile hypoglycemia due to combined fructose-1,6-diphosphatase deficiency and growth hormone deficiency.

Authors:  Dania Takagi; Josef Ben-Ari; Dan Nemet; Avraham Zeharia; Alon Eliakim
Journal:  J Pediatr Endocrinol Metab       Date:  2013       Impact factor: 1.634

7.  Cortisol and growth hormone responses to spontaneous hypoglycaemia in infants and children.

Authors:  P M Crofton; P C Midgley
Journal:  Arch Dis Child       Date:  2004-05       Impact factor: 3.791

8.  Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline.

Authors:  Philip E Cryer; Lloyd Axelrod; Ashley B Grossman; Simon R Heller; Victor M Montori; Elizabeth R Seaquist; F John Service
Journal:  J Clin Endocrinol Metab       Date:  2008-12-16       Impact factor: 5.958

9.  Recommendations from the Pediatric Endocrine Society for Evaluation and Management of Persistent Hypoglycemia in Neonates, Infants, and Children.

Authors:  Paul S Thornton; Charles A Stanley; Diva D De Leon; Deborah Harris; Morey W Haymond; Khalid Hussain; Lynne L Levitsky; Mohammad H Murad; Paul J Rozance; Rebecca A Simmons; Mark A Sperling; David A Weinstein; Neil H White; Joseph I Wolfsdorf
Journal:  J Pediatr       Date:  2015-05-06       Impact factor: 4.406

10.  Moderate neonatal hypoglycemia and adverse neurological development at 2-6 years of age.

Authors:  Ronny Wickström; Beatrice Skiöld; Gunnar Petersson; Olof Stephansson; Maria Altman
Journal:  Eur J Epidemiol       Date:  2018-07-20       Impact factor: 8.082

View more
  1 in total

Review 1.  Growth hormone deficiency and replacement in children.

Authors:  Margaret C S Boguszewski
Journal:  Rev Endocr Metab Disord       Date:  2020-10-08       Impact factor: 6.514

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.